135 related articles for article (PubMed ID: 6176332)
1. Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. I. Virus-specific and nonspecific components of the cytotoxic response.
Wallace LE; Rickinson AB; Rowe M; Moss DJ; Allen DJ; Epstein MA
Cell Immunol; 1982 Feb; 67(1):129-40. PubMed ID: 6176332
[No Abstract] [Full Text] [Related]
2. Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. II. Cytotoxic response to repeated stimulation.
Allen DJ; Rickinson AB; Wallace LE; Rowe M; Moss DJ; Epstein MA
Cell Immunol; 1982 Feb; 67(1):141-51. PubMed ID: 6176333
[No Abstract] [Full Text] [Related]
3. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
Klein E; Masucci MG
Springer Semin Immunopathol; 1982; 5(1):63-73. PubMed ID: 6314570
[No Abstract] [Full Text] [Related]
4. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
Wasik M; Myc A; Matej H; Rudzka L
Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
[TBL] [Abstract][Full Text] [Related]
5. Long-term T-cell-mediated immunity to Epstein-Barr virus.
Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH
Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
[No Abstract] [Full Text] [Related]
6. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
Hank JA; Sondel PM
Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468
[TBL] [Abstract][Full Text] [Related]
7. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
Enssle KH; Fleischer B
Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
[TBL] [Abstract][Full Text] [Related]
8. Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line.
Rickinson AB; Moss DJ; Allen DJ; Wallace LE; Rowe M; Epstein MA
Int J Cancer; 1981 May; 27(5):593-601. PubMed ID: 6169663
[TBL] [Abstract][Full Text] [Related]
9. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
Strang G; Rickinson AB
Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228
[TBL] [Abstract][Full Text] [Related]
10. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
[TBL] [Abstract][Full Text] [Related]
11. Education of mouse lymphocytes against human lymphoblastoid cell lines: specific recognition of determinants independent of serologically defined HLA allotypes and Epstein-Barr virus-coded antigens.
Carnaud C; Errasti P; van der Gaag R
Eur J Immunol; 1979 Oct; 9(10):802-8. PubMed ID: 93053
[No Abstract] [Full Text] [Related]
12. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
Strang G; Rickinson AB
Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F
Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728
[TBL] [Abstract][Full Text] [Related]
14. Isoprinosine enhances the activation of sensitized lymphocytes by Epstein-Barr virus antigens.
Sundar SK; Barile G; Menezes J
Int J Immunopharmacol; 1985; 7(2):187-92. PubMed ID: 2409036
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.
Moss DJ; Wallace LE; Rickinson AB; Epstein MA
Eur J Immunol; 1981 Sep; 11(9):686-93. PubMed ID: 6170517
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen.
Wallace LE; Rickinson AB; Rowe M; Epstein MA
Nature; 1982 Jun; 297(5865):413-5. PubMed ID: 6176881
[No Abstract] [Full Text] [Related]
17. Cytolytic human T-cell clones expressing Epstein-Barr virus specificity and HLA restriction.
Sethi KK; Stroehmann I; Brandis H
Immunobiology; 1981; 160(3-4):274-88. PubMed ID: 6173309
[No Abstract] [Full Text] [Related]
18. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules.
Chen BP; DeMars R; Hank JA; Sondel PM
Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068
[TBL] [Abstract][Full Text] [Related]
19. An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants.
Burrows SR; Misko IS; Sculley TB; Schmidt C; Moss DJ
J Virol; 1990 Aug; 64(8):3974-6. PubMed ID: 1695259
[TBL] [Abstract][Full Text] [Related]
20. Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens.
Seeley J; Svedmyr E; Weiland O; Klein G; Moller E; Eriksson E; Andersson K; van der Waal L
J Immunol; 1981 Jul; 127(1):293-300. PubMed ID: 6263974
[No Abstract] [Full Text] [Related]
[Next] [New Search]
